Open
SectorHealthcare
1.04 -8.77
24h
Min
1.05
Max
1.1400000000000001
Income | 1.8M -32M |
|---|---|
Sales | -166K 1.7M |
Profit margin | -1,852.384 |
Employees | 181 |
EBITDA | 7.9M -29M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +320.69% upside |
Next Earnings | 3 mar 2026 |
|---|
Market Cap | 16M 142M |
|---|---|
Previous open | 9.81 |
Previous close | 1.04 |
By Acuity
38%
62%
109 / 352 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 4.88 USD 320.69%
High 8 USD
Low 2 USD
Based on 6 Wall Street analysts offering 12 month price targets forFate Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$